Financhill
Back

Cellectis SA Vs. ResMed Industry Stock Comparison

Sell
32

CLLS
Cellectis SA

Last Price:
1.86
Seasonality Move:
-7.5%
Sell
30

RMD
ResMed

Last Price:
191.79
Seasonality Move:
6.67%
Sell
32
Cellectis SA (CLLS) is a Sell

Is Cellectis SA a Buy, Sell or Hold?

  • The current Cellectis SA [CLLS] share price is $1.87. The Score for CLLS is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • CLLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
ResMed (RMD) is a Sell

Is ResMed a Buy, Sell or Hold?

  • The current ResMed [RMD] share price is $191.42. The Score for RMD is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RMD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

  • The Cellectis SA share price today is $1.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing slight buying pressure.

RMD Stock Price Chart

What is ResMed's stock price today?

  • The ResMed share price today is $191.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RMD is experiencing slight selling pressure.

CLLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 21.49 Sell
Chaikin Money Flow: 303 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.01 - 2.73) Sell
Bollinger Bands (100): (2.34 - 2.96) Sell

RMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.24 Sell
Relative Strength Index (14 RSI): 36.96 Sell
Chaikin Money Flow: -790759 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (195.99 - 215.37) Sell
Bollinger Bands (100): (182.26 - 211.22) Sell

CLLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.91 Sell
20-day SMA: 2.27 Sell
50-day SMA: 2.61 Sell
200-day SMA: 2.52 Sell
8-day EMA: 1.96 Sell
20-day EMA: 2.21 Sell
50-day EMA: 2.47 Sell
200-day EMA: 2.56 Sell

RMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 195.87 Sell
20-day SMA: 204.74 Sell
50-day SMA: 207.09 Sell
200-day SMA: 177.56 Buy
8-day EMA: 194.67 Sell
20-day EMA: 201.7 Sell
50-day EMA: 203.15 Sell
200-day EMA: 191.93 Sell

Cellectis SA Earnings Growth & CLLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.47 per share, and a decrease next year of $0.53 per share.

ResMed Earnings Growth & RMD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, an increase next quarter of $0.07 per share, an increase this year of $1.20 per share, and an increase next year of $0.90 per share.

Cellectis SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ResMed Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):